Search research articles
Contact Us
Filters
Showing results (381-390 of 531) with videos related to
Page
of 54
Sort By:
JNCI Cancer Spectrum
|
July 31, 2019
Clinical Importance of Myc Family Oncogene Aberrations in Epithelial Ovarian Cancer
MoonSun Jung, Amanda J Russell, Catherine Kennedy, et al.
International Journal of Cancer
|
March 1, 1996
Involvement of MDR1 P-glycoprotein in multifactorial resistance to methotrexate
M D Norris, D De Graaf, M Haber, et al.
Plos One
|
December 28, 2020
A Neolithic mega-tsunami event in the eastern Mediterranean: Prehistoric settlement vulnerability along the Carmel coast, Israel
Gilad Shtienberg, Assaf Yasur-Landau, Richard D Norris, et al.
Journal of Endourology
|
November 11, 2006
Forced versus minimal intravenous hydration in the management of acute renal colic: a randomized trial
W Patrick Springhart, Charles G Marguet, Roger L Sur, et al.
British Journal of Cancer
|
July 14, 2005
The retinoid anticancer signal: mechanisms of target gene regulation
T Liu, A Bohlken, S Kuljaca, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 18, 2004
Mechanisms of embryonal tumor initiation: distinct roles for MycN expression and MYCN amplification
Loen M Hansford, Wayne D Thomas, Joanna M Keating, et al.
Congenital Heart Disease
|
December 31, 2013
Cone reconstruction in children with Ebstein anomaly: the Mayo Clinic experience
Heather N Anderson, Joseph A Dearani, Sameh M Said, et al.
Breast Cancer Research and Treatment
|
September 29, 2019
Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy
Suzanne E Wardell, Alexander P Yllanes, Christina A Chao, et al.
Breast Cancer Research and Treatment
|
November 18, 2019
Correction to: Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy
Suzanne E Wardell, Alexander P Yllanes, Christina A Chao, et al.
Cancer
|
May 15, 1990
A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin
S Cullinan, C G Moertel, H S Wieand, et al.
Page
of 54
Search research articles
Search
Showing results (381-390 of 531) with videos related to
Sort By:
Page
of 54
JNCI Cancer Spectrum
|
July 31, 2019
Clinical Importance of Myc Family Oncogene Aberrations in Epithelial Ovarian Cancer
MoonSun Jung, Amanda J Russell, Catherine Kennedy, et al.
International Journal of Cancer
|
March 1, 1996
Involvement of MDR1 P-glycoprotein in multifactorial resistance to methotrexate
M D Norris, D De Graaf, M Haber, et al.
Plos One
|
December 28, 2020
A Neolithic mega-tsunami event in the eastern Mediterranean: Prehistoric settlement vulnerability along the Carmel coast, Israel
Gilad Shtienberg, Assaf Yasur-Landau, Richard D Norris, et al.
Journal of Endourology
|
November 11, 2006
Forced versus minimal intravenous hydration in the management of acute renal colic: a randomized trial
W Patrick Springhart, Charles G Marguet, Roger L Sur, et al.
British Journal of Cancer
|
July 14, 2005
The retinoid anticancer signal: mechanisms of target gene regulation
T Liu, A Bohlken, S Kuljaca, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 18, 2004
Mechanisms of embryonal tumor initiation: distinct roles for MycN expression and MYCN amplification
Loen M Hansford, Wayne D Thomas, Joanna M Keating, et al.
Congenital Heart Disease
|
December 31, 2013
Cone reconstruction in children with Ebstein anomaly: the Mayo Clinic experience
Heather N Anderson, Joseph A Dearani, Sameh M Said, et al.
Breast Cancer Research and Treatment
|
September 29, 2019
Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy
Suzanne E Wardell, Alexander P Yllanes, Christina A Chao, et al.
Breast Cancer Research and Treatment
|
November 18, 2019
Correction to: Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy
Suzanne E Wardell, Alexander P Yllanes, Christina A Chao, et al.
Cancer
|
May 15, 1990
A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin
S Cullinan, C G Moertel, H S Wieand, et al.
Page
of 54